caa a22 4500 605478996 CHVBK 20210128100408.0 cr unu---uuuuu 210128e20150701xx s 000 0 eng 10.1007/s10741-015-9489-4 doi (NATIONALLICENCE)springer-10.1007/s10741-015-9489-4 TakoTsubo cardiomyopathy: unravelling the malignant consequences of a benign disease with cardiac magnetic resonance [Elektronische Daten] [Amardeep Dastidar, Antonio Frontera, Alberto Palazzuoli, Chiara Bucciarelli-Ducci] TakoTsubo cardiomyopathy (TCM) is a unique type of reversible cardiomyopathy that is precipitated by a stressful emotional or physical event. The increasing incidence is due to the greater use of emergency coronary angiography, newer cardiac biomarkers together with more sensitive cardiac imaging techniques. Few case reports have documented how TCM can present with malignant arrhythmias such as torsades de pointes caused by the repolarisation abnormalities or QTc prolongation. Although TCM is usually considered a benign reversible condition, its associated arrhythmic risk is increasingly recognised. TCM often presents as an acute coronary syndrome with unobstructed coronary arteries at angiography. In this patient population, cardiac magnetic resonance (CMR) is a useful tool to establish a differential diagnosis, discriminating TCM from acute myocarditis and myocardial infarction with spontaneous recanalisation. CMR is becoming a promising new diagnostic modality in risk stratifying patients with potential higher arrhythmic risk. Springer Science+Business Media New York, 2015 TakoTsubo cardiomyopathy nationallicence Cardiac MRI nationallicence CMR nationallicence Dastidar Amardeep NIHR Cardiovascular Biomedical Research Unit, Bristol Heart Institute, University of Bristol, BS2 8HW, Bristol, UK aut Frontera Antonio NIHR Cardiovascular Biomedical Research Unit, Bristol Heart Institute, University of Bristol, BS2 8HW, Bristol, UK aut Palazzuoli Alberto NIHR Cardiovascular Biomedical Research Unit, Bristol Heart Institute, University of Bristol, BS2 8HW, Bristol, UK aut Bucciarelli-Ducci Chiara NIHR Cardiovascular Biomedical Research Unit, Bristol Heart Institute, University of Bristol, BS2 8HW, Bristol, UK aut Heart Failure Reviews Springer US; http://www.springer-ny.com 20/4(2015-07-01), 415-421 1382-4147 20:4<415 2015 20 10741 https://doi.org/10.1007/s10741-015-9489-4 text/html Onlinezugriff via DOI BK010053 XK010053 XK010000 Metadata rights reserved Springer special CC-BY-NC licence nationallicence 1 research-article jats NATIONALLICENCE NATIONALLICENCE NL-springer NATIONALLICENCE 856 40 https://doi.org/10.1007/s10741-015-9489-4 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Dastidar Amardeep NIHR Cardiovascular Biomedical Research Unit, Bristol Heart Institute, University of Bristol, BS2 8HW, Bristol, UK aut NATIONALLICENCE 700 1- Frontera Antonio NIHR Cardiovascular Biomedical Research Unit, Bristol Heart Institute, University of Bristol, BS2 8HW, Bristol, UK aut NATIONALLICENCE 700 1- Palazzuoli Alberto NIHR Cardiovascular Biomedical Research Unit, Bristol Heart Institute, University of Bristol, BS2 8HW, Bristol, UK aut NATIONALLICENCE 700 1- Bucciarelli-Ducci Chiara NIHR Cardiovascular Biomedical Research Unit, Bristol Heart Institute, University of Bristol, BS2 8HW, Bristol, UK aut NATIONALLICENCE 773 0- Heart Failure Reviews Springer US; http://www.springer-ny.com 20/4(2015-07-01), 415-421 1382-4147 20:4<415 2015 20 10741